Eye Infections [clinicaltrials_resource:0b2ee0f51a48e49b9fc21af7281b6970]
Endophthalmitis Vitrectomy Study (EVS) [clinicaltrials:NCT00000130]A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte [clinicaltrials:NCT00198523]Local Moxifloxacin and Povidone Iodine Versus Povidone Iodine Alone as a Prophylaxis Before Eye Operations [clinicaltrials:NCT00335088]clinicaltrials:NCT00564447clinicaltrials:NCT00575367clinicaltrials:NCT00575380clinicaltrials:NCT01739920The Influence of Hospital Environment on Eyes Infections in Medical Staff [clinicaltrials:NCT01817478]
condition [clinicaltrials_vocabulary:condition]
Endophthalmitis Vitrectomy Study (EVS) [clinicaltrials:NCT00000130]A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte [clinicaltrials:NCT00198523]clinicaltrials:NCT00324168Local Moxifloxacin and Povidone Iodine Versus Povidone Iodine Alone as a Prophylaxis Before Eye Operations [clinicaltrials:NCT00335088]Effectiveness Study of Zymar Versus Vigamox for Preoperative Sterilization of the Ocular Surface After Loading Dose [clinicaltrials:NCT00347828]Azithromycin Level in Tears and in Conjunctiva in 36 Healthy Volunteers [clinicaltrials:NCT00356772]Ocular Pharmacokinetics After a Single Drop Instillation of T1225 0.5, 1, 1.5% in 91 Healthy Volunteers [clinicaltrials:NCT00356850]Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy Volunteers [clinicaltrials:NCT00357292]Study of the Ocular Safety After Repeated Instillations of T1225 1% or 1.5% Eye Drops in Healthy Volunteers [clinicaltrials:NCT00357383]Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy Volunteers [clinicaltrials:NCT00357539]clinicaltrials:NCT00564447clinicaltrials:NCT00575367clinicaltrials:NCT00575380clinicaltrials:NCT00996736clinicaltrials:NCT00997035Non-Inferiority of Gatifloxacin/Prednisolone Association vs Isolated Administration in Prevention of Ocular Infection/Inflammation [clinicaltrials:NCT01218737]clinicaltrials:NCT01603030clinicaltrials:NCT01739920The Influence of Hospital Environment on Eyes Infections in Medical Staff [clinicaltrials:NCT01817478]clinicaltrials:NCT01853722clinicaltrials:NCT02163824
condition browse [clinicaltrials_vocabulary:condition-browse]
Endophthalmitis Vitrectomy Study (EVS) [clinicaltrials:NCT00000130]A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte [clinicaltrials:NCT00198523]clinicaltrials:NCT00324168Local Moxifloxacin and Povidone Iodine Versus Povidone Iodine Alone as a Prophylaxis Before Eye Operations [clinicaltrials:NCT00335088]Effectiveness Study of Zymar Versus Vigamox for Preoperative Sterilization of the Ocular Surface After Loading Dose [clinicaltrials:NCT00347828]Azithromycin Level in Tears and in Conjunctiva in 36 Healthy Volunteers [clinicaltrials:NCT00356772]Ocular Pharmacokinetics After a Single Drop Instillation of T1225 0.5, 1, 1.5% in 91 Healthy Volunteers [clinicaltrials:NCT00356850]Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy Volunteers [clinicaltrials:NCT00357292]Study of the Ocular Safety After Repeated Instillations of T1225 1% or 1.5% Eye Drops in Healthy Volunteers [clinicaltrials:NCT00357383]Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy Volunteers [clinicaltrials:NCT00357539]clinicaltrials:NCT00564447clinicaltrials:NCT00575367clinicaltrials:NCT00575380clinicaltrials:NCT00996736clinicaltrials:NCT00997035Non-Inferiority of Gatifloxacin/Prednisolone Association vs Isolated Administration in Prevention of Ocular Infection/Inflammation [clinicaltrials:NCT01218737]clinicaltrials:NCT01603030clinicaltrials:NCT01739920The Influence of Hospital Environment on Eyes Infections in Medical Staff [clinicaltrials:NCT01817478]clinicaltrials:NCT01853722clinicaltrials:NCT02163824
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Eye Infections [clinicaltrials_resource:0b2ee0f51a48e49b9fc21af7281b6970]
Bio2RDF identifier
0b2ee0f51a48e49b9fc21af7281b6970
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0b2ee0f51a48e49b9fc21af7281b6970
identifier
clinicaltrials_resource:0b2ee0f51a48e49b9fc21af7281b6970
title
Eye Infections
@en
type
label
Eye Infections [clinicaltrials_resource:0b2ee0f51a48e49b9fc21af7281b6970]
@en
Eye Infections